Hormone control breakthrough from Ergopharm
Ergopharm proudly introduces 11 OXO, the first selective inhibitor of 11b-hydroxysteroid dehydrogenase type I reductase. Finally, cortisol control that delivers on the promises.
Ergopharm has found the key to obtaining: - Decreased body fat (especially visceral adipose tissue) - Increased muscle density (hardness) - Enhanced insulin sensitivity and glycogen deposition - Increased strength - Improved brain and CNS function
Cart is empty
